(Reuters) — Merck & Co is nearing a $1.3 billion cash deal to buy ophthalmology biotechnology company Eyebiotech in an agreement that could see an additional $1.7 billion in milestone payments, the Wall Street Journal reported on Tuesday. The deal could be announced as early as Wednesday, the report said, citing people familiar with the […]